An pilot study to assess the efficacy of intravenous iron isomaltoside 1000 (Monofer) in the management of anaemia associated with the palliative management of upper gastrointestinal adenocarcinoma
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Ferric derisomaltose (Primary)
- Indications Chemotherapy-induced anaemia
- Focus Therapeutic Use
- Acronyms IRON
- 07 Jun 2019 This trial has been completed in UK.
- 27 Oct 2016 Planned End Date changed from 31 Dec 2015 to 1 Aug 2017.
- 26 Sep 2015 Accrual to date is 40% according to United Kingdom Clinical Research Network record.